Pharmafile Logo

Anopheles stephensi

Can Cinderella save us?

Conference discusses global targets in fight against antimicrobial resistance

World Health Organization reports show AMR is one of the top ten threats to global health

- PMLiVE

Novartis and MMV to advance new malaria drug combination to phase 3 study

The announcement comes as the threat of resistance to current malaria treatments grows

- PMLiVE

WHO launches R&D efforts to identify pathogens that could cause future pandemics

Over 300 scientists will convene to discuss over 25 virus and bacteria, including ‘Disease X’

- PMLiVE

World Antimicrobial Awareness Week 2022

Reports from the World Health Organization show that AMR is one of the top ten threats to global health

- PMLiVE

WHO, WIPO and WTO to hold technical symposium on pandemic preparedness

The event will examine ways to build resilience to be better prepared for future pandemics

- PMLiVE

Act-Accelerator outlines plans for longterm COVID-19 control

Its plan highlights key priorities as countries transition to manage the public health issue

- PMLiVE

WHO reveals tuberculosis deaths rose due to COVID-19 disruption

An estimated 10.6 million were infected with TB in 2021, an increase of 4.5% from 2020

- PMLiVE

WHO publishes first-ever fungal priority pathogens list in face of antimicrobial resistance

The list highlights the public health threat presented by fungal infections on a global scale

- PMLiVE

Merck to donate Sudan Ebola virus vaccine to International AIDS Vaccine Initiative

Around 50,000 doses are expected to be provided for further clinical research use

- PMLiVE

WHO partners with IANPHI to strengthen health emergency preparedness

The two organisations will work together to enhance national public health capacities

- PMLiVE

Global leaders pledge $2.6bn at World Health Summit in efforts to end polio

The pledging moment was a milestone in fulfilling the $4.8bn required to implement the GPEI Strategy

- PMLiVE

WHO unveils AI-powered digital health worker, Florence 2.0

The chatbot builds on its previous version, which was used to tackle COVID-19 misinformation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links